Literature DB >> 9611085

Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder.

J Zihl1, G Grön, A Brunnauer.   

Abstract

This study was designed to determine whether patients with schizophrenia and those with affective disorders display a common pattern of cognitive deficits. Cognitive performance was assessed with a neuropsychological test battery in consecutively admitted in-patients with schizophrenia (n=100) and affective disorders (n=100). The two groups of patients showed a similar pattern of cognitive deficits, especially in tests focusing on attentional capacities. The groups only differed significantly in their performance on the Wisconsin Card Sorting Test (WCST), with the schizophrenic patients performing less well. These results suggest that, with the exception of the deficit as measured by the WCST, similar cognitive impairments exist in schizophrenia and affective disorders, even at very early stages of the illness. Therefore, patients with schizophrenia and those with affective disorders cannot be qualitatively distinguished with sufficient reliability. We postulate that the cognitive deficit pattern represents a final common pathway disorder in the two groups of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9611085     DOI: 10.1111/j.1600-0447.1998.tb10014.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

1.  Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.

Authors:  Paul G Unschuld; Suresh E Joel; James J Pekar; Sarah A Reading; Kenichi Oishi; Julie McEntee; Megan Shanahan; Arnold Bakker; Russell L Margolis; Susan S Bassett; Adam Rosenblatt; Susumu Mori; Peter C van Zijl; Christopher A Ross; Graham W Redgrave
Journal:  Psychiatry Res       Date:  2012-09-11       Impact factor: 3.222

2.  Neurocognition and social skill in older persons with schizophrenia and major mood disorders: An analysis of gender and diagnosis effects.

Authors:  Kim T Mueser; Sarah I Pratt; Stephen J Bartels; Brent Forester; Rosemarie Wolfe; Corinne Cather
Journal:  J Neurolinguistics       Date:  2010-05       Impact factor: 1.710

3.  Cholinergic enhancement of episodic memory in healthy young adults.

Authors:  Georg Grön; Matthias Kirstein; Axel Thielscher; Matthias W Riepe; Manfred Spitzer
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Driving skills in unmedicated first- and recurrent-episode schizophrenic patients.

Authors:  Felix M Segmiller; Verena Buschert; Gerd Laux; N Nedopil; Ulrich Palm; Katharina Furjanic; Peter Zwanzger; Alexander Brunnauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10-25       Impact factor: 5.270

5.  Cariprazine, a dopamine D(3)-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse.

Authors:  Ross Zimnisky; Gloria Chang; István Gyertyán; Béla Kiss; Nika Adham; Claudia Schmauss
Journal:  Psychopharmacology (Berl)       Date:  2012-10-19       Impact factor: 4.530

Review 6.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

Review 7.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

8.  Cognitive factors for predicting treatment response in schizophrenic patients: one-year follow-up study.

Authors:  Yong-Ku Kim; Ae-Ra Lee; Ji-Won Hur; Ho-Kyung Yoon; Bun-Hee Lee; Young-Hoon Ko
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

9.  Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis.

Authors:  Taís M Minatogawa-Chang; Maristela S Schaufelberger; Adriana M Ayres; Fábio L S Duran; Elisa K Gutt; Robin M Murray; Teresa M Rushe; Philip K McGuire; Paulo R Menezes; Marcia Scazufca; Geraldo F Busatto
Journal:  Schizophr Res       Date:  2009-07-17       Impact factor: 4.939

Review 10.  The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.

Authors:  B S McEwen; S Chattarji; D M Diamond; T M Jay; L P Reagan; P Svenningsson; E Fuchs
Journal:  Mol Psychiatry       Date:  2009-08-25       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.